HsingChing Hsu v. Puma Biotechnology, Inc. et al

  1. June 03, 2015

    Puma Hit With Stock Drop Suit Over Breast Cancer Drug

    Puma Biotechnology Inc. was hit with a putative class action for allegedly misleading investors about a new drug application for neratinib, with a California federal court being told Wednesday that Puma abruptly shifted course on the breast cancer drug's proposed use and timeline.